Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2025 Earnings Call Transcript February 26, 2026
Anika Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.1228, expectations were $0.02.
Operator: Good morning, ladies and gentlemen, and welcome to Anika’s Fourth Quarter and Year-End Earnings Conference Call. [Operator Instructions] This call is being recorded on Thursday, February 26, 2026. I would now like to turn the call over to Matt Hall, Executive Director, Corporate Development...
